Cigna Corporation has revised its policy on coverage of exoskeleton medical devices for people with spinal cord injury (SCI). Previously, the insurer had a non-coverage policy, but they now plan to review submissions on a case-by-case basis. The policy change is already in effect.
The policy revision is the first of its kind by any major private insurer for people who are eligible for exoskeleton devices. However, in 2015, the Department of Veterans Affairs set out a national policy for the evaluation, training in, and procurement of ReWalk’s Personal exoskeleton systems for all qualifying veterans in the U.S.
According to the National Spinal Cord Injury Statistical Center, there are approximately 17,700 new SCI cases each year. The current number of people with SCI in the U.S. is estimated at 288,000.
ReWalk Robotics Ltd., whose U.S. location is in Massachusetts, develops and manufactures wearable robotic exoskeletons for individuals with lower limb disabilities resulting from spinal cord injury or stroke.
Source: ReWalk Robotics, Ltd., February 13, 2019